NAVER D2SF

Activity from announced rounds

Activity in this selectionHardware

NAVER D2SF is NAVER’s startup investment organization, identified through official materials for ImpriMed and NdotLight.

Recorded funding activity

ImpriMed combines live-cell drug testing with clinical data. NdotLight generates simulation-ready 3D data, while F4GE structures factory information for industrial buyers. The organization retains its identity separately from NAVER Ventures and the parent.

Sources
Rounds participated in
1
Confirmed lead rounds
—
1 roles undisclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

Pre-seed1

By primary sector

Robotics1

By country

South Korea1

Rounds

1 in this selection